Axl-IN-17 (compound 13c) is an orally active, selective AXL inhibitor with an IC 50 value of 3.2 nM. Axl-IN-17 reveals antitumor efficacy.
Products | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Signaling Pathways > TAM Receptor
感谢您来到爆牛贸易,请为我们留言或者使用以下方式联系我们,我们将尽快给您回复,并为您提供最真诚的服务,谢谢。